Literature DB >> 36102963

Polar map-free 3D deep learning algorithm to predict obstructive coronary artery disease with myocardial perfusion CZT-SPECT.

Chi-Lun Ko1,2,3, Shau-Syuan Lin1, Cheng-Wen Huang1, Yu-Hui Chang1, Kuan-Yin Ko4, Mei-Fang Cheng2,3, Shan-Ying Wang5, Chung-Ming Chen1, Yen-Wen Wu6,7,8,9,10,11.   

Abstract

PURPOSE: Deep learning (DL) models have been shown to outperform total perfusion deficit (TPD) quantification in predicting obstructive coronary artery disease (CAD) from myocardial perfusion imaging (MPI). However, previously published methods have depended on polar maps, required manual correction, and normal database. In this study, we propose a polar map-free 3D DL algorithm to predict obstructive disease.
METHODS: We included 1861 subjects who underwent MPI using cadmium-zinc-telluride camera and subsequent coronary angiography. The subjects were divided into parameterization and external validation groups. We implemented a fully automatic algorithm to segment myocardium, perform registration, and apply normalization. We further flattened the image based on spherical coordinate system transformation. The proposed model consisted of a component to predict patent arteries and a component to predict disease in each vessel. The model was cross-validated in the parameterization group, and then further tested using the external validation group. The performance was assessed by area under receiver operating characteristic curves (AUCs) and compared with TPD.
RESULTS: Our algorithm preprocessed all images accurately as confirmed by visual inspection. In patient-based analysis, the AUC of the proposed model was significantly higher than that for stress-TPD (0.84 vs 0.76, p < 0.01). In vessel-based analysis, the proposed model also outperformed regional stress-TPD (AUC = 0.80 vs 0.72, p < 0.01). The addition of quantitative images did not improve the performance.
CONCLUSIONS: Our proposed polar map-free 3D DL algorithm to predict obstructive CAD from MPI outperformed TPD and did not require manual correction or a normal database.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Artificial intelligence; Cadmium-zinc-telluride; Coronary artery disease; Deep learning; Myocardial perfusion imaging

Year:  2022        PMID: 36102963     DOI: 10.1007/s00259-022-05953-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   10.057


  28 in total

Review 1.  2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Stephan D Fihn; James C Blankenship; Karen P Alexander; John A Bittl; John G Byrne; Barbara J Fletcher; Gregg C Fonarow; Richard A Lange; Glenn N Levine; Thomas M Maddox; Srihari S Naidu; E Magnus Ohman; Peter K Smith
Journal:  J Am Coll Cardiol       Date:  2014-07-28       Impact factor: 24.094

2.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.

Authors:  Juhani Knuuti; William Wijns; Antti Saraste; Davide Capodanno; Emanuele Barbato; Christian Funck-Brentano; Eva Prescott; Robert F Storey; Christi Deaton; Thomas Cuisset; Stefan Agewall; Kenneth Dickstein; Thor Edvardsen; Javier Escaned; Bernard J Gersh; Pavel Svitil; Martine Gilard; David Hasdai; Robert Hatala; Felix Mahfoud; Josep Masip; Claudio Muneretto; Marco Valgimigli; Stephan Achenbach; Jeroen J Bax
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

Review 3.  Diagnostic Accuracy of Myocardial Perfusion Imaging With CZT Technology: Systemic Review and Meta-Analysis of Comparison With Invasive Coronary Angiography.

Authors:  Francesco Nudi; Ami E Iskandrian; Orazio Schillaci; Mariangela Peruzzi; Giacomo Frati; Giuseppe Biondi-Zoccai
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

4.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983

5.  Prognostic Value of Myocardial Perfusion Imaging with a Cadmium-Zinc-Telluride SPECT Camera in Patients Suspected of Having Coronary Artery Disease.

Authors:  Elsemiek M Engbers; Jorik R Timmer; Mohamed Mouden; Siert Knollema; Pieter L Jager; Jan Paul Ottervanger
Journal:  J Nucl Med       Date:  2017-04-27       Impact factor: 10.057

6.  The Incremental Diagnostic Performance of Coronary Computed Tomography Angiography Added to Myocardial Perfusion Imaging in Patients with Intermediate-to-High Cardiovascular Risk.

Authors:  Pei-Ying Hsu; Wen-Jeng Lee; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

Review 7.  Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM).

Authors:  Denis Agostini; Pierre-Yves Marie; Simona Ben-Haim; François Rouzet; Bernard Songy; Alessandro Giordano; Alessia Gimelli; Fabien Hyafil; Roberto Sciagrà; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-19       Impact factor: 9.236

8.  Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy.

Authors:  Francesco Nudi; Natale Di Belardino; Francesco Versaci; Annamaria Pinto; Enrica Procaccini; Giandomenico Neri; Maurizio Vetere; Giacomo Frati; Mariangela Peruzzi; Orazio Schillaci; Achille Gaspardone; Fabrizio Tomai; Giuseppe Biondi-Zoccai
Journal:  J Nucl Cardiol       Date:  2016-05-26       Impact factor: 5.952

9.  JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases.

Authors:  Masakazu Yamagishi; Nagara Tamaki; Takashi Akasaka; Takanori Ikeda; Kenji Ueshima; Shiro Uemura; Yutaka Otsuji; Yasuki Kihara; Kazuo Kimura; Takeshi Kimura; Yoshiki Kusama; Shinichiro Kumita; Hajime Sakuma; Masahiro Jinzaki; Hiroyuki Daida; Yasuchika Takeishi; Hiroshi Tada; Taishiro Chikamori; Kenichi Tsujita; Kunihiko Teraoka; Kenichi Nakajima; Tomoaki Nakata; Satoshi Nakatani; Akihiko Nogami; Koichi Node; Atsushi Nohara; Atsushi Hirayama; Nobusada Funabashi; Masaru Miura; Teruhito Mochizuki; Hiroyoshi Yokoi; Kunihiro Yoshioka; Masafumi Watanabe; Toshihiko Asanuma; Yuichi Ishikawa; Takahiro Ohara; Koichi Kaikita; Tokuo Kasai; Eri Kato; Hiroshi Kamiyama; Masaaki Kawashiri; Keisuke Kiso; Kakuya Kitagawa; Teruhito Kido; Toshio Kinoshita; Tomonari Kiriyama; Teruyoshi Kume; Akira Kurata; Satoshi Kurisu; Masami Kosuge; Eitaro Kodani; Akira Sato; Yasutsugu Shiono; Hiroki Shiomi; Junichi Taki; Masaaki Takeuchi; Atsushi Tanaka; Nobuhiro Tanaka; Ryoichi Tanaka; Takuya Nakahashi; Takehiro Nakahara; Akihiro Nomura; Akiyoshi Hashimoto; Kenshi Hayashi; Masahiro Higashi; Takafumi Hiro; Daisuke Fukamachi; Hitoshi Matsuo; Naoya Matsumoto; Katsumi Miyauchi; Masao Miyagawa; Yoshitake Yamada; Keiichiro Yoshinaga; Hideki Wada; Tetsu Watanabe; Yukio Ozaki; Shun Kohsaka; Wataru Shimizu; Satoshi Yasuda; Hideaki Yoshino
Journal:  Circ J       Date:  2021-02-16       Impact factor: 2.993

10.  Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging.

Authors:  Chia-Ju Liu; Yen-Wen Wu; Kuan-Yin Ko; Yi-Chieh Chen; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.